Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,438 signal articles · 135 in last 24h · 154,019 total before filter · latest 1h ago
135last 24h
869last 7d
144● bullish (7d)
99● bearish (7d)
214publishers
AllMacro207Earnings105M&A125Regulatory22Product21Analyst16
✕ clear all filtersticker: ^GSPCsentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
3 Reasons to Avoid SHW and 1 Stock to Buy Instead
StockStory7h agobullish
3 Reasons to Avoid SHW and 1 Stock to Buy Instead

Sherwin-Williams currently trades at $326.33 per share and has shown little upside over the past six months, posting a middling return of 4%. The stock also fell short of the S&P 500’s 18.4% gain during that period.

3 Reasons to Avoid AMPH and 1 Stock to Buy Instead
StockStory7h agobullish
3 Reasons to Avoid AMPH and 1 Stock to Buy Instead

Over the past six months, Amphastar Pharmaceuticals has been a great trade, beating the S&P 500 by 11.4%. Its stock price has climbed to $24.97, representing a healthy 29.8% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

3 Reasons MYGN is Risky and 1 Stock to Buy Instead
StockStory7h agobullish
3 Reasons MYGN is Risky and 1 Stock to Buy Instead

Over the past six months, Myriad Genetics’s stock price fell to $4.01. Shareholders have lost 13% of their capital, which is disappointing considering the S&P 500 has climbed by 18.4%. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Earnings Outlook Remains Upbeat: A Closer Look
Zacks1d agobullish
Earnings Outlook Remains Upbeat: A Closer Look

Earnings revisions remain positive, sustaining a trend that's been in place for a year now. Q3 earnings are currently expected to grow 23.9% year-over-year, reflecting the eighth consecutive quarter of double-digit growth for the S&P 500 index.

Should You Buy Royal Caribbean At A One-Year Low?
Trefis1d agobullish
Should You Buy Royal Caribbean At A One-Year Low?

Royal Caribbean (RCL) trades near $235, at its 52-week low, and over the past year the stock returned about -27% against close to 18% for the S&P 500. The easy read on a cruise line down that far is that demand cracked. It did not. The company lifted its earnings outlook for 2026 and expects adjusted earnings per share to grow 14%, and what has stalled, in the third quarter of 2026, is the price it can put on a cabin.

Should You Buy Carnival Stock While Europe Sails Emptier?
Trefis1d agobullish
Should You Buy Carnival Stock While Europe Sails Emptier?

Carnival Corporation (CCL) trades near $22, down about 26% over the past year, while the S&P 500 gained close to 18%. The easy read on a cruise line that cheap is that demand finally cracked. It has not. Carnival lowered its 2026 yield outlook after the Middle East conflict hit its European sailings, and part of that cut was its own choice to protect price rather than fill cabins.

Is Snowflake Buying Its Growth With Its Margin?
Trefis1d agobullish
Is Snowflake Buying Its Growth With Its Margin?

Snowflake (SNOW) stock has gained about 50% since late December 2025, against 13% for the S&P 500. Microsoft, Amazon, and Alphabet all trailed the index over the same stretch. So this was not the cloud trade lifting everything at once. One number inside Snowflake moved, and management has already said what it costs to keep it moving.

3 Reasons LNTH is Risky and 1 Stock to Buy Instead
StockStory1d agobullish
3 Reasons LNTH is Risky and 1 Stock to Buy Instead

Lantheus currently trades at $100.02 and has been a dream stock for shareholders. It’s returned 270% since September 2021, blowing past the S&P 500’s 74.5% gain. The company has also beaten the index over the past six months as its stock price is up 32.1% thanks to its solid quarterly results.